PharmacogeneticsWarfarinVitamin K Epoxide ReductasesAnticoagulantsAryl Hydrocarbon HydroxylasesMixed Function OxygenasesIndividualized MedicineBiomarkers, PharmacologicalPolymorphism, GeneticCytochrome P-450 CYP2D6Drug-Related Side Effects and Adverse ReactionsGenotypePharmaceutical PreparationsDrug TherapyInternational CooperationKnowledge BasesPolymorphism, Single NucleotideMetabolic Detoxication, DrugGenetic VariationProthrombin TimeHemorrhageThromboembolismAtrial FibrillationMicrobial ConsortiaGenetic TestingGenome-Wide Association StudyDrug DesignPharmacokineticsCytochrome P-450 Enzyme SystemEducation, Pharmacy, ContinuingGenome, Humanbeta-AlanineVitamin KDrug Dosage Calculations6-MercaptopurineInternational AgenciesMethyltransferasesDrug InteractionsTreatment OutcomePhenotypeClinical Trials as TopicGenomicsRodenticidesBiotransformationPharmacology, ClinicalTranslational Medical ResearchDose-Response Relationship, DrugPharmacy ResidenciesGenetic ServicesNeoplasmsAcenocoumarolAntineoplastic AgentsUnited StatesGenetic Predisposition to DiseaseStrokeDihydrouracil Dehydrogenase (NADP)Cardiovascular AgentsInternationalityImmunogenetic ProcessesDrug MonitoringMedical OncologyUnited States Food and Drug AdministrationAspirinDrug RepositioningVitamin K 1Platelet Aggregation InhibitorsCytochrome P-450 CYP3AInterdisciplinary StudiesHuman Genome ProjectTiclopidineRisk FactorsHaplotypesCongresses as TopicXenobioticsDatabases, FactualInternational Normalized Ratio